ID   WEE2_HUMAN              Reviewed;         567 AA.
AC   P0C1S8;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   15-MAR-2017, entry version 102.
DE   RecName: Full=Wee1-like protein kinase 2;
DE            EC=2.7.10.2;
DE   AltName: Full=Wee1-like protein kinase 1B;
DE   AltName: Full=Wee1B kinase;
GN   Name=WEE2; Synonyms=WEE1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11029659; DOI=10.1046/j.1365-2443.2000.00367.x;
RA   Nakanishi M., Ando H., Watanabe N., Kitamura K., Ito K., Okayama H.,
RA   Miyamoto T., Agui T., Sasaki M.;
RT   "Identification and characterization of human Wee1B, a new member of
RT   the Wee1 family of Cdk-inhibitory kinases.";
RL   Genes Cells 5:839-847(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-8; LYS-332; HIS-398; GLU-470 AND
RP   ASP-526.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Oocyte-specific protein tyrosine kinase that
CC       phosphorylates and inhibits CDK1 and acts as a key regulator of
CC       meiosis during both prophase I and metaphase II. Required to
CC       maintain meiotic arrest in oocytes during the germinal vesicle
CC       (GV) stage, a long period of quiescence at dictyate prophase I, by
CC       phosphorylating CDK1 at 'Tyr-15', leading to inhibit CDK1 activity
CC       and prevent meiotic reentry. Also required for metaphase II exit
CC       during egg activation by phosphorylating CDK1 at 'Tyr-15', to
CC       ensure exit from meiosis in oocytes and promote pronuclear
CC       formation (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10027}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11029659}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis.
CC       {ECO:0000269|PubMed:11029659}.
CC   -!- PTM: Phosphorylation leads to increase its activity.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. WEE1 subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK131218; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC004918; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS43660.1; -.
DR   RefSeq; NP_001099028.1; NM_001105558.1.
DR   UniGene; Hs.657927; -.
DR   ProteinModelPortal; P0C1S8; -.
DR   SMR; P0C1S8; -.
DR   BioGrid; 138978; 1.
DR   STRING; 9606.ENSP00000380675; -.
DR   BindingDB; P0C1S8; -.
DR   ChEMBL; CHEMBL5095; -.
DR   GuidetoPHARMACOLOGY; 2279; -.
DR   iPTMnet; P0C1S8; -.
DR   PhosphoSitePlus; P0C1S8; -.
DR   BioMuta; WEE2; -.
DR   DMDM; 254763343; -.
DR   PaxDb; P0C1S8; -.
DR   PeptideAtlas; P0C1S8; -.
DR   PRIDE; P0C1S8; -.
DR   Ensembl; ENST00000397541; ENSP00000380675; ENSG00000214102.
DR   Ensembl; ENST00000574659; ENSP00000459392; ENSG00000263042.
DR   GeneID; 494551; -.
DR   KEGG; hsa:494551; -.
DR   UCSC; uc003vwn.2; human.
DR   CTD; 494551; -.
DR   GeneCards; WEE2; -.
DR   H-InvDB; HIX0007154; -.
DR   H-InvDB; HIX0033848; -.
DR   HGNC; HGNC:19684; WEE2.
DR   HPA; HPA027418; -.
DR   MIM; 614084; gene.
DR   neXtProt; NX_P0C1S8; -.
DR   OpenTargets; ENSG00000214102; -.
DR   PharmGKB; PA134909633; -.
DR   eggNOG; KOG0601; Eukaryota.
DR   eggNOG; ENOG410XS1M; LUCA.
DR   GeneTree; ENSGT00530000063230; -.
DR   HOGENOM; HOG000004824; -.
DR   HOVERGEN; HBG005050; -.
DR   InParanoid; P0C1S8; -.
DR   KO; K06632; -.
DR   OMA; ICHKMQS; -.
DR   OrthoDB; EOG091G049H; -.
DR   PhylomeDB; P0C1S8; -.
DR   TreeFam; TF101088; -.
DR   SignaLink; P0C1S8; -.
DR   GenomeRNAi; 494551; -.
DR   PRO; PR:P0C1S8; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000214102; -.
DR   CleanEx; HS_WEE2; -.
DR   ExpressionAtlas; P0C1S8; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007143; P:female meiotic division; ISS:UniProtKB.
DR   GO; GO:0035038; P:female pronucleus assembly; ISS:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:InterPro.
DR   GO; GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:1900194; P:negative regulation of oocyte maturation; ISS:UniProtKB.
DR   GO; GO:0060631; P:regulation of meiosis I; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR017164; Wee1-like_protein_kinase.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037281; Wee1-like_protein_kinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Coiled coil; Complete proteome; Kinase; Magnesium;
KW   Meiosis; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1    567       Wee1-like protein kinase 2.
FT                                /FTId=PRO_0000248079.
FT   DOMAIN      212    486       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     218    226       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COILED      494    519       {ECO:0000255}.
FT   MOTIF       173    175       Nuclear localization signal.
FT                                {ECO:0000250}.
FT   MOTIF       315    329       Nuclear export signal. {ECO:0000250}.
FT   ACT_SITE    339    339       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   METAL       344    344       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       380    380       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   BINDING     241    241       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A4PES0}.
FT   VARIANT       8      8       K -> T (in dbSNP:rs35672788).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041304.
FT   VARIANT     332    332       N -> K (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041305.
FT   VARIANT     398    398       R -> H (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs200610853).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041306.
FT   VARIANT     470    470       D -> E (in dbSNP:rs55901099).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041307.
FT   VARIANT     526    526       Y -> D (in dbSNP:rs35683659).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041308.
FT   CONFLICT    351    351       M -> V (in Ref. 2; AK131218).
FT                                {ECO:0000305}.
FT   CONFLICT    529    529       H -> Y (in Ref. 2; AK131218).
FT                                {ECO:0000305}.
SQ   SEQUENCE   567 AA;  62925 MW;  BC05DDFE96D87E3F CRC64;
     MDDKDIDKEL RQKLNFSYCE ETEIEGQKKV EESREASSQT PEKGEVQDSE AKGTPPWTPL
     SNVHELDTSS EKDKESPDQI LRTPVSHPLK CPETPAQPDS RSKLLPSDSP STPKTMLSRL
     VISPTGKLPS RGPKHLKLTP APLKDEMTSL ALVNINPFTP ESYKKLFLQS GGKRKIRGDL
     EEAGPEEGKG GLPAKRCVLR ETNMASRYEK EFLEVEKIGV GEFGTVYKCI KRLDGCVYAI
     KRSMKTFTEL SNENSALHEV YAHAVLGHHP HVVRYYSSWA EDDHMIIQNE YCNGGSLQAA
     ISENTKSGNH FEEPKLKDIL LQISLGLNYI HNSSMVHLDI KPSNIFICHK MQSESSGVIE
     EVENEADWFL SANVMYKIGD LGHATSINKP KVEEGDSRFL ANEILQEDYR HLPKADIFAL
     GLTIAVAAGA ESLPTNGAAW HHIRKGNFPD VPQELSESFS SLLKNMIQPD AEQRPSAAAL
     ARNTVLRPSL GKTEELQQQL NLEKFKTATL ERELREAQQA QSPQGYTHHG DTGVSGTHTG
     SRSTKRLVGG KSARSSSFTS GEREPLH
//
